国际简称:CURR REV CLIN EXP PH 参考译名:临床和实验药理学最新评论
主要研究方向:PHARMACOLOGY & PHARMACY 非预警期刊
《临床和实验药理学最新评论》(Current Reviews In Clinical And Experimental Pharmacology)是一本由Bentham出版的以PHARMACOLOGY & PHARMACY为研究特色的国际期刊,发表该领域相关的原创研究文章、评论文章和综述文章,及时报道该领域相关理论、实践和应用学科的最新发现,旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊,近三年没有被列入预警名单。
Current Reviews in Clinical and Experimental Pharmacology is a peer-reviewed journal dedicated to the field of clinical and experimental pharmacology. This magazine aims to provide a platform for publishing review articles on drug mechanisms of action, pharmacodynamics, pharmacokinetics, drug therapy, and new drug development. It covers a wide range of topics from basic research to clinical applications, aiming to promote scientific exchange and knowledge updates in the field of pharmacology. The characteristic of a journal is its comprehensive review of the latest research findings, which is typically based on extensive literature reviews and provides in-depth analysis of specific drug categories or therapeutic fields. This form of article is highly valuable for researchers, clinical doctors, and students as it can help readers quickly grasp the current research status and future directions in a particular field.
The editorial team of the magazine is composed of experienced pharmacologists who ensure that the published articles have high academic standards and practical application value. In addition, journals may regularly invite leading figures in the field to write invited reviews to further enhance their influence in the academic community. It is an important academic resource dedicated to promoting the development of clinical and experimental pharmacology, suitable for professionals seeking in-depth understanding of the latest developments in drug research to read and reference.
| CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||||||
| 4.1 | 0.55 | 0.811 |
|
名词解释:CiteScore 是衡量期刊所发表文献的平均受引用次数,是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年(含计算年度)的被引次数除以该期刊近四年发表的文献数。例如,2022年的 CiteScore 计算方法为:2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量 注:文献类型包括:文章、评论、会议论文、书籍章节和数据论文。
| Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
| 否 | 否 | 医学 | 4区 | PHARMACOLOGY & PHARMACY 药学 | 4区 |
| 按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
| 学科:PHARMACOLOGY & PHARMACY | ESCI | Q3 | 231 / 356 |
35.3 |
| 学科:PHARMACOLOGY & PHARMACY | ESCI | Q4 | 282 / 356 |
20.93 |
Frontiers In Public Health
中科院 3区 JCR Q1
Frontiers In Pharmacology
中科院 2区 JCR Q1
Biomedicine & Pharmacotherapy
中科院 2区 JCR Q1
Discover Oncology
中科院 3区 JCR Q3
Medcomm
中科院 1区 JCR Q1
Bmc Psychiatry
中科院 2区 JCR Q1
Bmc Neurology
中科院 3区 JCR Q3
Public Health Nursing
中科院 4区 JCR Q3